Jim Cramer Put These 15 Stocks Under the Microscope
“At last, the drug companies are trying to reclaim their old mantle as the safest place to be in a slowdown.
No. | Hedge Fund | Shares | Value | Activity | % Port |
---|---|---|---|---|---|
1. | Cantillon Capital Management William Von Mueffling | 18,687,995 | $364,229,023 | -3% | 2.11% |
2. | Renaissance Technologies Jim Simons | 8,363,490 | $163,004,420 | +4% | 0.22% |
3. | Keystone Investors Liu Xuan | 3,525,623 | $68,714,392 | +2975% | 14.18% |
4. | Driehaus Capital Richard Driehaus | 3,444,934 | $67,141,764 | 0.54% | |
5. | Marshall Wace LLP Paul Marshall And Ian Wace | 1,129,681 | $22,017,483 | +289% | 0.02% |
No. | Name | Shares | Value | % Port |
---|---|---|---|---|
1. | 1,202,899 | $28,075,663 | 0.35% | |
2. | 570,919 | $13,325,249 | 0.01% | |
3. | 280,311 | $6,542,459 | 0.06% | |
4. | 157,230 | $3,669,748 | 0% | |
5. | 91,468 | $1,940,613 | 0.03% |